These data suggest that cell cycle dysfunction is the fundamental cause of GEP-NENs, and that the differences in the clinical features and malignancy of these neoplasms arise from their different pathway mutations; mTOR pathway mutations in GEP-NETs, and TP53 and RB pathway mutations in GEP-NECs. This evidence concerns the gene MTOR and neoplasm.